Dr. Bharat Bhushan is an Ohio Eminent Scholar and The Howard D. Winbigler Professor, and the Director of the Nanoprobe Laboratory for Bio- & Nanotechnology and Biomimetics at the Ohio State University, Columbus, Ohio. He is also serving as an ASME/AAAS Science & Technology Policy Fellow, House Committee on Science, Space & Technology, United States Congress, Washington, DC. He holds two M.S., a Ph.D. in mechanical engineering/mechanics, an MBA, and four honorary doctorates. His research interests include fundamental studies with a focus on scanning probe techniques in the interdisciplinary areas of bio/nanotribology, bio/nanomechanics and bio/nanomaterials characterization and applications to bio/nanotechnology
Dr. Bharat Bhushan is an Ohio Eminent Scholar and The Howard D. Winbigler Professor, and the Director of the Nanoprobe Laboratory for Bio- & Nanotechnology and Biomimetics at the Ohio State University, Columbus, Ohio. He is also serving as an ASME/AAAS Science & Technology Policy Fellow, House Committee on Science, Space & Technology, United States Congress, Washington, DC. He holds two M.S., a Ph.D. in mechanical engineering/mechanics, an MBA, and four honorary doctorates. His research interests include fundamental studies with a focus on scanning probe techniques in the interdisciplinary areas of bio/nanotribology, bio/nanomechanics and bio/nanomaterials characterization and applications to bio/nanotechnology and biomimetics. He has authored 8 books and 800+ papers, holds 19 patents and is ISI highly-cited researcher. He is co-editor of several books and journals. He is the recipient of numerous prestigious awards and international fellowships. He is a member of the International Academy of Engineering (Russia).
I received my PhD from University of Florida where I worked on population pharmacokinetic approaches to establish bioequivalence of inhaled drugs with emphasis on inhaled corticosteroids. I am highly interested in the use of quantitative and population model based analyses approach in research and development of new treatments. Such approaches are critical in efficient utilization of the shrinking resources in Pharma R&D. There is a growing appreciation within the industry and regulators regarding the role of quantitative clinical pharmacology in reducing the time and resources needed to take a drug candidate into clinic followed by successful registration. Early understanding of
I received my PhD from University of Florida where I worked on population pharmacokinetic approaches to establish bioequivalence of inhaled drugs with emphasis on inhaled corticosteroids. I am highly interested in the use of quantitative and population model based analyses approach in research and development of new treatments. Such approaches are critical in efficient utilization of the shrinking resources in Pharma R&D. There is a growing appreciation within the industry and regulators regarding the role of quantitative clinical pharmacology in reducing the time and resources needed to take a drug candidate into clinic followed by successful registration. Early understanding of drug exposure-response (efficacy and safety) is key to having fewer failed candidate molecules which in turn would bring down R&D costs significantly. His reserch interests are Design and analyses of first-time-in-human, proof-of-concept, exposure-response and drug-drug interaction clinical pharmacology studies.
Dr. Mansour is an Assistant Professor of Medicine at Stony Brook University Medical Center, where he currently serves as Director of the Medical Intensive Care Unit. Dr. Mansour completed his Fellowship in Pulmonary and Critical Care Medicine, at Stony Brook University, under the tutelage of Gerald C. Smaldone, MD. His research interests include medical applications of aerosolized particles, in the context of both delivery of medication and control of airborne infection. Dr. Mansours teaching initiatives at Stony Brook University include airway management, percutaneous tracheostomy and focused assessment with ultrasonography for critical care physicians. He is the President of Mansour
Dr. Mansour is an Assistant Professor of Medicine at Stony Brook University Medical Center, where he currently serves as Director of the Medical Intensive Care Unit. Dr. Mansour completed his Fellowship in Pulmonary and Critical Care Medicine, at Stony Brook University, under the tutelage of Gerald C. Smaldone, MD. His research interests include medical applications of aerosolized particles, in the context of both delivery of medication and control of airborne infection. Dr. Mansours teaching initiatives at Stony Brook University include airway management, percutaneous tracheostomy and focused assessment with ultrasonography for critical care physicians. He is the President of Mansour Consulting Services, a clinical and research consulting corporation.
Prof. Kyuzi Kamoi was born August 28, 1943 in Tokyo, Japan. He received his MD in 1970 and his MSD in 1982, both from the Medical School of Niigata University, Niigata, Japan. He has received the following certificates: Japan Medical Diplomat (1970), Japan Board of Diabetes Mellitus (1990), Japan Board of Endocrinology and Metabolism (1991), Certified Diabetes Mellitus Educator (1993), Certified Endocrine Educator (2004). From 1980 to 2010 he was Chief of Internal Medicine, and from 2002 until 2010 the Director of Center of Diabetes Mellitus and Endocrine Disease at Nagaoka Red Cross Hospital, Japan. Since 2010 to the present
Prof. Kyuzi Kamoi was born August 28, 1943 in Tokyo, Japan. He received his MD in 1970 and his MSD in 1982, both from the Medical School of Niigata University, Niigata, Japan. He has received the following certificates: Japan Medical Diplomat (1970), Japan Board of Diabetes Mellitus (1990), Japan Board of Endocrinology and Metabolism (1991), Certified Diabetes Mellitus Educator (1993), Certified Endocrine Educator (2004). From 1980 to 2010 he was Chief of Internal Medicine, and from 2002 until 2010 the Director of Center of Diabetes Mellitus and Endocrine Disease at Nagaoka Red Cross Hospital, Japan. Since 2010 to the present he has been Professor of Niigata Prefecture University. He is a member of The Japanese Society of Internal Medicine, The Japan Endocrine Society, The Japanese Society of Hypertension, The Japan Society of Hypertension, the Endocrine Society, The American Society of Hypertension, The American Diabetes Association, The International Diabetes Federation and the New York Academy of Science. He has published a total of 200 scientific papers.
Professor Zhou is presently the Associate Vice President of Global Medical Development & Associate Dean of International Research, College of Pharmacy, University of South Florida, Tampa (USF), Florida. USF is one of only 25 public research universities nationwide with very high research activity that is also designated as community engaged by the Carnegie Foundation for the Advancement of Teaching. USF is a global research university ranked 34th in federal research expenditures for public universities and is one of the fastest growing in federal funding in the US. Professor Zhou completed his clinical medical training in China in 1989 and obtained
Professor Zhou is presently the Associate Vice President of Global Medical Development & Associate Dean of International Research, College of Pharmacy, University of South Florida, Tampa (USF), Florida. USF is one of only 25 public research universities nationwide with very high research activity that is also designated as community engaged by the Carnegie Foundation for the Advancement of Teaching. USF is a global research university ranked 34th in federal research expenditures for public universities and is one of the fastest growing in federal funding in the US. Professor Zhou completed his clinical medical training in China in 1989 and obtained his PhD in 2001 from the School of Medicine, the University of Auckland, New Zealand. Since 2002, Dr Zhou has served as an Assistant Professor, Senior Lecturer, Associate Professor and Professor for the National University of Singapore, Queensland University of Technology, RMIT University in Australia, and now at USF. Dr Zhous major research interests are systems pharmacology, drug metabolism & drug transport, pharmacokinetics/pharmacometrics, pharmacogenomics, nanomedicine and Chinese medicine.
Dr. Vickie Shannon is a board certified Pulmonary and Critical Care Specialist. She is a full Professor in the Department of Pulmonary Medicine and Director of the Pulmonary Rehabilitation Program at MD Anderson Cancer Center. Dr. Shannon received her medical degree and completed her fellowship training in Pulmonary and Critical Care Medicine at Washington University in St. Louis, Missouri. Board certified in Internal Medicine, Critical Care, and Pulmonary Medicine, she is also a member of the American College of Chest Physicians, American Association of Cardiovascular and Pulmonary Rehabilitation, American Lung Association, and American College of Physicians, to name a
Dr. Vickie Shannon is a board certified Pulmonary and Critical Care Specialist. She is a full Professor in the Department of Pulmonary Medicine and Director of the Pulmonary Rehabilitation Program at MD Anderson Cancer Center. Dr. Shannon received her medical degree and completed her fellowship training in Pulmonary and Critical Care Medicine at Washington University in St. Louis, Missouri. Board certified in Internal Medicine, Critical Care, and Pulmonary Medicine, she is also a member of the American College of Chest Physicians, American Association of Cardiovascular and Pulmonary Rehabilitation, American Lung Association, and American College of Physicians, to name a few. Dr. Shannon is widely sought nationally and internationally as a guest lecturer. Her research interests focus on pulmonary rehabilitation in the cancer setting, lung injury due to drug toxicity, muscle physiology, respiratory physiology, and exercise physiology.
Dr. Jiachun Lu, MD., Ph. D., Professor of epidemiology, Principal Investigator of State Key Laboratory of Respiratory Disease, Academic Committee Member, Guangzhou Medical University, China. He has been on faculty since 1994, and trained in the University of Texas, MD Anderson Cancer Center as a postdoctoral fellow during 2005 to 2007. Dr. Lu is involved in many studies investigating the molecular epidemiology of lung cancer, COPD and other respiratory diseases with particular focus on its frequency, risk factors and genetic susceptibility in large populations. He also involved in the epidemiology of other cancers. In his lab, with both traditional and
Dr. Jiachun Lu, MD., Ph. D., Professor of epidemiology, Principal Investigator of State Key Laboratory of Respiratory Disease, Academic Committee Member, Guangzhou Medical University, China. He has been on faculty since 1994, and trained in the University of Texas, MD Anderson Cancer Center as a postdoctoral fellow during 2005 to 2007. Dr. Lu is involved in many studies investigating the molecular epidemiology of lung cancer, COPD and other respiratory diseases with particular focus on its frequency, risk factors and genetic susceptibility in large populations. He also involved in the epidemiology of other cancers. In his lab, with both traditional and molecular epidemiology, they conducted research based on the blueprint of Find the associations between exposures and disease in population studies - Validate the association with functional assays in laboratory - Guide the prevention of disease in population, funded by more than seven projects of National Nature Science Foundation of China. Dr. Lu has published more than 80 research articles in SCI journals, including corresponse author in Am J Respir Crit Care Med., Am J Hum Genet., Hum Mol Genet., Human Mutat., Hum Genet., Carcinogenesis, Mol Carcinog., Int J Cancer, and co-author in Nat Genet., Lancet, BMJ, PLoS Genet., Gastroenterology, and Cancer Res., with >3600 citations, >550 impact factor scores and a 24 H-index score.
The overall objective of my research program is to understand metabolic basis and mechanism of alcoholic pancreatitis. I have worked on several federally funded projects as PI and Co-Investigator for the last twenty-five years and published extensively in the area of alcohol models and mechanism of alcoholic pancreatitis. Since chronic alcohol abuse impairs hepatic alcohol dehydrogenase (ADH, major enzyme responsible for ethanol oxidation), we are using hepatic ADH deficient (ADH-) deer mice to understand the metabolic basis and mechanism of alcoholic pancreatitis. Currently, I am working in AMPK signaling and lipid metabolomics including the analysis of oxidative and nonoxidative metabolites
The overall objective of my research program is to understand metabolic basis and mechanism of alcoholic pancreatitis. I have worked on several federally funded projects as PI and Co-Investigator for the last twenty-five years and published extensively in the area of alcohol models and mechanism of alcoholic pancreatitis. Since chronic alcohol abuse impairs hepatic alcohol dehydrogenase (ADH, major enzyme responsible for ethanol oxidation), we are using hepatic ADH deficient (ADH-) deer mice to understand the metabolic basis and mechanism of alcoholic pancreatitis. Currently, I am working in AMPK signaling and lipid metabolomics including the analysis of oxidative and nonoxidative metabolites of ethanol in the pancreas and plasma of ethanol-fed hepatic ADH- deer mice and in isolated human pancreatic acinar cells exposed to ethanol to understand the etiopathogenesis of alcoholic pancreatitis. My research programs are supported by funding from the National Institute on Alcohol Abuse and Alcoholism and John Sealy Memorial Endowment Funds for Biomedical Research. I am also working on lipid metabolomic and proteomic profiling and ethanol-induced ER stress mechanisms in alcoholic pancreatitis in our deer mouse model for the discovery of biomarker(s) and therapeutic target(s). Understanding the etiopathogenesis of alcoholic pancreatitis and identifying metabolic basis and mechanism(s) of alcoholic pancreatitis as proposed in this application appears to be critical for dissecting the role of ethanol metabolism and metabolites in the development and progression of chronic pancreatitis (PA-14-198).
Prof Nicolino Ambrosino is Research Director and Director of Cardio-Respiratory Department, Rehabilitation and Weaning Center, Auxilium Vitae, Volterra, and is and/or has been appointed professor at Italian Universities of Pisa, Pavia, Firenze, Trieste, Milano, Siena, Genova. His research activity has been devoted to COPD, Respiratory Critical Care, Pulmonary Rehabilitation and Home Respiratory Care. He contributed to the development of the use of Non-invasive Mechanical Ventilation techniques in acute and chronic respiratory failure with several clinical trials and original experimental studies. Results of such studies have been published in more than 200 international articles (PubMed) with more than 4000 Citations, at
Prof Nicolino Ambrosino is Research Director and Director of Cardio-Respiratory Department, Rehabilitation and Weaning Center, Auxilium Vitae, Volterra, and is and/or has been appointed professor at Italian Universities of Pisa, Pavia, Firenze, Trieste, Milano, Siena, Genova. His research activity has been devoted to COPD, Respiratory Critical Care, Pulmonary Rehabilitation and Home Respiratory Care. He contributed to the development of the use of Non-invasive Mechanical Ventilation techniques in acute and chronic respiratory failure with several clinical trials and original experimental studies. Results of such studies have been published in more than 200 international articles (PubMed) with more than 4000 Citations, at May 2014. (Source Research Gate) (Web of Science H Index 37, Research Gate Score 43.51) Former Secretary of Clinical Assembly and head of Pulmonary Rehabilitation Working Group of the European Respiratory Society (ERS), Chief Editor of the European Respiratory Topics, and Co-Editor of Breath he is at present Director of External Postgraduate Courses of ERS School years 2013-2016, Co-Chair: ERS Task Force on Telemonitoring in Ventilator Dependent patients and a member of the Editorial Boards of several International Journals.
The broad focus of Chens lab is to investigate genetic and epigenetic regulations of genes in human lung cancer related to environmental or occupational exposure to mineral dust and carcinogenic metals. More specifically, the lab employs pharmaceutical and biochemical approaches to elucidate molecular mechanisms by which the expression and function of genes contributing to lung inflammation and tumorigenesis are altered. One of the key signaling events in environmental factor-induced carcinogenesis is the aberrant alternation of the epigenetic landscape on the genes important for glycolysis, oxidative phosphorylation, self-renewal, and differentiation of the normal cells, adult stem cells, cancer cells, and cancer
The broad focus of Chens lab is to investigate genetic and epigenetic regulations of genes in human lung cancer related to environmental or occupational exposure to mineral dust and carcinogenic metals. More specifically, the lab employs pharmaceutical and biochemical approaches to elucidate molecular mechanisms by which the expression and function of genes contributing to lung inflammation and tumorigenesis are altered. One of the key signaling events in environmental factor-induced carcinogenesis is the aberrant alternation of the epigenetic landscape on the genes important for glycolysis, oxidative phosphorylation, self-renewal, and differentiation of the normal cells, adult stem cells, cancer cells, and cancer stem cells. A principal question to be addressed is how extracellular inducers, such as cytokines, ROS and carcinogenic metals, perturb the intracellular regulatory circuits that control cross-talk, durability and potency of a wide spectrum of intracellular signaling pathways.
Hildegard M. Schuller, D.V.M., Ph.D. is director of the Experimental Oncology Laboratory and Distinguished Professor of Comparative Pathology, Department of Biomedical & Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee Knoxville, TN, USA. She held positions as Assistant and Associate Professor at the Medical School Hannover (Germany), appointments as group leader at the NCI Frederick Cancer Research Center, Frederick, MD and section chief, Division of Cancer Treatment, NCI, Bethesda, MD. Dr. Schuller joined the University of Tennessee in 1985. Dr. Schullers research focuses on the role of neurotransmitters in the development and progression of lung cancer and pancreatic cancer
Hildegard M. Schuller, D.V.M., Ph.D. is director of the Experimental Oncology Laboratory and Distinguished Professor of Comparative Pathology, Department of Biomedical & Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee Knoxville, TN, USA. She held positions as Assistant and Associate Professor at the Medical School Hannover (Germany), appointments as group leader at the NCI Frederick Cancer Research Center, Frederick, MD and section chief, Division of Cancer Treatment, NCI, Bethesda, MD. Dr. Schuller joined the University of Tennessee in 1985. Dr. Schullers research focuses on the role of neurotransmitters in the development and progression of lung cancer and pancreatic cancer as targets for cancer intervention. Dr. Schuller is the discoverer of a growth-regulating role of nicotinic acetylcholine receptors for small cell lung cancer and of beta-adrenergic receptors and GABA-B receptors for adenocarcinomas of the lungs and pancreas. Dr. Schuller has published 242 peer-reviewed articles in national and international journals.
Deborah R. Tasat is Professor at the Center for the Study of Health and the Environment at the School of Science and Technology of the University of San Martin (UNSAM) and Professor of Histology and Embryology at the School of Dentistry from the University of Buenos Aires, Argentina. She worked for the National Commission of Atomic Energy, at Buenos Aires and was appointed as visiting scientist at the University of Colorado Springs at Colorado Springs, CO, USA and as staff member for the Department of Environmental Health, Harvard School of Public Health, MA, USA. Her research interest focuses on the
Deborah R. Tasat is Professor at the Center for the Study of Health and the Environment at the School of Science and Technology of the University of San Martin (UNSAM) and Professor of Histology and Embryology at the School of Dentistry from the University of Buenos Aires, Argentina. She worked for the National Commission of Atomic Energy, at Buenos Aires and was appointed as visiting scientist at the University of Colorado Springs at Colorado Springs, CO, USA and as staff member for the Department of Environmental Health, Harvard School of Public Health, MA, USA. Her research interest focuses on the study of the impact of environmental and occupational pollutants (gases and particulate matter) on health. Of particular interest is the role of lung macrophages, as a critical regulator of inflammatory and immune responses, to micro and nano particles. Her diverse research activities include: Particle Health Effects; Physico-Chemical and Toxicological Characterization of Micro and Nanoparticles; Tribocorrosion of Metallic Biomedical devices and the Study of the Implant Particle-Tissue Interfaces. Her studies extend from the deposition of inhaled particles in the respiratory tract or release of particles into the peri-implant milleu to their local or systemic biodistirbution and cytotoxic effects in the organism. Dr. Tasat is currently the Director of the Lung Cell Biology Laboratory at the School of Science and Technology, UNSAM, and of the Environmental Monitoring Laboratory at the Lincoln College Center, Argentina.
My research focuses on the association between sleep apnea and cardiovascular diseases. My laboratory examines the burden of oxidative stress on endothelial function and the link to endothelial apoptosis. As part of a VA merit review grant, we are engaged in determining the impact of obstructive sleep apnea on the manifestations of post-traumatic stress disorder (PTSD) in veterans and whether treatment of sleep apnea alleviates the debilitating symptoms of PTSD. Toward that goal, we have adopted a patented screening tool to identify patients with sleep apnea. My research in the critical care arena involves the epidemiology and risk factors of
My research focuses on the association between sleep apnea and cardiovascular diseases. My laboratory examines the burden of oxidative stress on endothelial function and the link to endothelial apoptosis. As part of a VA merit review grant, we are engaged in determining the impact of obstructive sleep apnea on the manifestations of post-traumatic stress disorder (PTSD) in veterans and whether treatment of sleep apnea alleviates the debilitating symptoms of PTSD. Toward that goal, we have adopted a patented screening tool to identify patients with sleep apnea. My research in the critical care arena involves the epidemiology and risk factors of Pseudomonas infections with the type III secretory system. The goal is to develop a rapid diagnostic tool to identify these organisms early in the course of infection. My other projects include studying the role of adjuvant treatment with corticosteroids in the management of severe community acquired pneumonia, such as nursing home acquired pneumonia, the management of morbidly obese critically ill patients and the long-term outcomes of elderly patients after treatment from a critical care ailment.
I completed my undergraduate degree at Johns Hopkins University in 1990 and did additional graduate studies and research at JHU and JHMI; I graduated from medical school at University of Maryland in 1996. I stayed at Maryland to be the first resident in the combined Emergency and Internal Medicine (EM-IM) program and later was chief resident; I completed my fellowship in Critical Care at the R Adams Cowley Shock Trauma Center at the U. of MD. Previously I had been on faculty at East Carolina University where I was Program Director of the EM-IM residency and Medical Director of the
I completed my undergraduate degree at Johns Hopkins University in 1990 and did additional graduate studies and research at JHU and JHMI; I graduated from medical school at University of Maryland in 1996. I stayed at Maryland to be the first resident in the combined Emergency and Internal Medicine (EM-IM) program and later was chief resident; I completed my fellowship in Critical Care at the R Adams Cowley Shock Trauma Center at the U. of MD. Previously I had been on faculty at East Carolina University where I was Program Director of the EM-IM residency and Medical Director of the Critical Care Consult service from 2001 to 2007; I then joined the Baylor College of Medicine faculty, where I was the Director of Emergency Critical Care at Ben Taub General Hospital and an Intensivist at The Methodist Hospital of Houston. Since 2011, I am an Associate Professor of Emergency Medicine and Surgical Critical Care at U. FL College of Medicine Jacksonville and the Co-Director of the SICU and NSICU at U FL Health. Research Interests are adult resuscitation, cardiovascular and neurovascular emergency and critical care, ARDS, medical education.
Shahid Ijaz Sheikh, MD, is a member of the Section of Pulmonary Medicine and Allergy/Immunology at Nationwide Childrens Hospital and an Associate Professor of Clinical Pediatrics at The Ohio State University College of Medicine. He is trained and certified in pediatric pulmonology and allergy and immunology. His clinical interests include children with asthma, bronchopulmonary dysplasia and cystic fibrosis. His research interests include asthma, infantile wheezing, cystic fibrosis and gastroesophageal reflux induced respiratory problems. He is involved in multiple clinical trials at Nationwide Childrens Hospital. He is also involved in physician development courses offered through the medical school. My research interests
Shahid Ijaz Sheikh, MD, is a member of the Section of Pulmonary Medicine and Allergy/Immunology at Nationwide Childrens Hospital and an Associate Professor of Clinical Pediatrics at The Ohio State University College of Medicine. He is trained and certified in pediatric pulmonology and allergy and immunology. His clinical interests include children with asthma, bronchopulmonary dysplasia and cystic fibrosis. His research interests include asthma, infantile wheezing, cystic fibrosis and gastroesophageal reflux induced respiratory problems. He is involved in multiple clinical trials at Nationwide Childrens Hospital. He is also involved in physician development courses offered through the medical school. My research interests are Asthma, Cystic Fibrosis.
Victor O. Kolade MD MS FACP is Internal Medicine Program Director at the Guthrie Clinic in Sayre, Pennsylvania. He is Clinical Associate Professor at the State University of New York Upstate Medical University and Adjunct Clinical Associate Professor at the Lake Erie College of Osteopathic Medicine. He is a board-certified internist and an epidemiologist; his publications have discussed asthma, lung cancer screening and smoking cessation. As an educator he is very interested in the intersection of teaching and scholarly activity among faculty and trainees.
Victor O. Kolade MD MS FACP is Internal Medicine Program Director at the Guthrie Clinic in Sayre, Pennsylvania. He is Clinical Associate Professor at the State University of New York Upstate Medical University and Adjunct Clinical Associate Professor at the Lake Erie College of Osteopathic Medicine. He is a board-certified internist and an epidemiologist; his publications have discussed asthma, lung cancer screening and smoking cessation. As an educator he is very interested in the intersection of teaching and scholarly activity among faculty and trainees.
Luis E. Raez, MD, FACP, FCCP; is the Medical Director of Memorial Cancer Institute (MCI), he is also the Oncology Research Director of Memorial Health Care System (MHS) and Director of the Thoracic Oncology Program. He is also Clinical Associate Professor of Medicine at Florida International University (FIU) and Visiting Professor of Medicine at Cayetano Heredia University in Peru. He was an Associate Professor of Medicine, Epidemiology and Public Health, and a Co-Director of Thoracic Oncology at Sylvester Cancer Center/University of Miami for 10 years (2001-2011). He has expertise in medical oncology in the areas of lung cancer, and
Luis E. Raez, MD, FACP, FCCP; is the Medical Director of Memorial Cancer Institute (MCI), he is also the Oncology Research Director of Memorial Health Care System (MHS) and Director of the Thoracic Oncology Program. He is also Clinical Associate Professor of Medicine at Florida International University (FIU) and Visiting Professor of Medicine at Cayetano Heredia University in Peru. He was an Associate Professor of Medicine, Epidemiology and Public Health, and a Co-Director of Thoracic Oncology at Sylvester Cancer Center/University of Miami for 10 years (2001-2011). He has expertise in medical oncology in the areas of lung cancer, and head and neck cancer. He designs phase I-III clinical trials with new chemotherapeutic agents and combinations. Dr. Raez does translational research in the areas of cancer vaccines. He has been funded by NCI and the pharma industry. He has given oral presentations and lectures in national and international meetings in the US, Europe, Latin-America and Asia. He has been the International Chair of the 2014 IASLC-Latin-American Meeting (LALCA); Chairman for the Miami Best of ASCO 2014, Chair and Founder of the Miami Cancer Meeting (MCM) since 2002, Co-Chairman at the Puerto Rico Fall Cancer Symposia (FCS) since 2010. He is American Board Certified in: Internal Medicine, Medical Oncology and Geriatric Medicine. He is board elegible in Hematology. He is a member of AACR, ESMO, ASCO, IASLC, ALLIANCE, NCCTG, ACCP, ACP, ACSG, FLASCO among other institutions.
Rajapriya Manickam is an Associate professor, PSG Institute of Medical Sciences and Research Instructor in pulmonary physiology, New York Medical College, USA. Done MD Pulmonary and Critical care Medicine, Westchester Medical center, Valhalla, NY, University Hospital of NY Medical College. she has completed MD Internal Medicine Residency Lincoln Medical center, Bronx, NY, United States, Affiliated to Weill Medical College of Cornell University. Her Research interests are Clinical research in critical care medicine, lung cancer, COPD.
Rajapriya Manickam is an Associate professor, PSG Institute of Medical Sciences and Research Instructor in pulmonary physiology, New York Medical College, USA. Done MD Pulmonary and Critical care Medicine, Westchester Medical center, Valhalla, NY, University Hospital of NY Medical College. she has completed MD Internal Medicine Residency Lincoln Medical center, Bronx, NY, United States, Affiliated to Weill Medical College of Cornell University. Her Research interests are Clinical research in critical care medicine, lung cancer, COPD.
Dr. Imran Iftikhar is an Associate Professor in the Division of Pulmonary, Critical care and Sleep Medicine. After 3 years of training in Internal Medicine at Fairview Hospital/Cleveland Clinic, Cleveland, Ohio, he completed 2 years of training in Pulmonary Medicine at the University of South Carolina, School of Medicine in 2010. He then, completed a year of training in Sleep Medicine at the Ohio State University, Columbus, Ohio. After his fellowship in Sleep Medicine, he joined the faculty of University of South Carolina, School of Medicine in July 2011. Dr. Iftikhar has published in several peer-reviewed journals and serves on
Dr. Imran Iftikhar is an Associate Professor in the Division of Pulmonary, Critical care and Sleep Medicine. After 3 years of training in Internal Medicine at Fairview Hospital/Cleveland Clinic, Cleveland, Ohio, he completed 2 years of training in Pulmonary Medicine at the University of South Carolina, School of Medicine in 2010. He then, completed a year of training in Sleep Medicine at the Ohio State University, Columbus, Ohio. After his fellowship in Sleep Medicine, he joined the faculty of University of South Carolina, School of Medicine in July 2011. Dr. Iftikhar has published in several peer-reviewed journals and serves on the editorial board for several journals and as ad-hoc reviewer for several others.
Dr. Gary Epler is an internationally-known pulmonary and critical care professor at Harvard Medical School in Boston. Recognized yearly since 1994 in The Best Doctors in America, Dr. Epler discovered the treatable lung disorder bronchiolitis obliterans organizing pneumonia (BOOP). He found a new parasite in South America, chronicled the nutritional needs of North African children, and managed the tuberculosis refugee program in Southeast Asia. In addition to conducting clinical and research work, Dr. Epler strives to educate. He became editor-in-chief of an internet-based educational program in critical care and pulmonary medicine offered by the American College of Chest Physicians. Business
Dr. Gary Epler is an internationally-known pulmonary and critical care professor at Harvard Medical School in Boston. Recognized yearly since 1994 in The Best Doctors in America, Dr. Epler discovered the treatable lung disorder bronchiolitis obliterans organizing pneumonia (BOOP). He found a new parasite in South America, chronicled the nutritional needs of North African children, and managed the tuberculosis refugee program in Southeast Asia. In addition to conducting clinical and research work, Dr. Epler strives to educate. He became editor-in-chief of an internet-based educational program in critical care and pulmonary medicine offered by the American College of Chest Physicians. Business Week acclaimed him for his development of e-health educational programs that enable patients to manage their health and diseases. Dr. Epler was recognized as one of Boston Magazines Top Doctors in Town. He has been one of the Boston Celtics team doctors. He has taught medicine throughout the world and was fortunate enough to save a dying infant in South America from an overwhelming parasitic infection by using the sap from a fig tree. He saved a baby who choked on a donut during a little league baseball game that he was coaching. He is active in the community. He coached soccer, basketball, hockey, baseball, and club baseball at Boston College. He lives in the Boston area with his wife, Joan.
Dr. Haibin wang received his Ph.D. from Peking University Health Science Center, China in 1999, and completed his postdoctoral fellowship training in 2002 at Division of Allergy, Inflammation and Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School. He has been remaining on the faculty of the same Division at Harvard for 12 years. His research focuses on the immunoregulatory roles of eosinophils, including roles for eosinophils as antigenÂpresenting cells in regulating regional and systemic T cell responses in allergic diseases including asthma, and roles of eosinophil-secreted cytokines in directing T cell differentiation and in B cell priming and activation.
Dr. Haibin wang received his Ph.D. from Peking University Health Science Center, China in 1999, and completed his postdoctoral fellowship training in 2002 at Division of Allergy, Inflammation and Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School. He has been remaining on the faculty of the same Division at Harvard for 12 years. His research focuses on the immunoregulatory roles of eosinophils, including roles for eosinophils as antigenÂpresenting cells in regulating regional and systemic T cell responses in allergic diseases including asthma, and roles of eosinophil-secreted cytokines in directing T cell differentiation and in B cell priming and activation. He has authored/co-authored over 20 peer-reviewed publications in international journals, books and conference proceedings.
I am currently working as a consultant doctor in Department of Medical Oncology, Beijing Tsinghua Changgung Hospital Medical Center, Tsinghua University. Previously, I worked in Department of Medical Oncology as the department chief for 7 years in No 309 PLA Hospital. My clinical practices and researches include medical oncology and chemotherapy resistance. I have treated thousands of cancer patients and majority of them are lung cancer patients. My research experiences have been shaped by my clinical interests. For the past 7 years, I have focused my research on overcoming lung cancer chemoresistance. By targeting cancer stem cells via inhibiting ABCG2
I am currently working as a consultant doctor in Department of Medical Oncology, Beijing Tsinghua Changgung Hospital Medical Center, Tsinghua University. Previously, I worked in Department of Medical Oncology as the department chief for 7 years in No 309 PLA Hospital. My clinical practices and researches include medical oncology and chemotherapy resistance. I have treated thousands of cancer patients and majority of them are lung cancer patients. My research experiences have been shaped by my clinical interests. For the past 7 years, I have focused my research on overcoming lung cancer chemoresistance. By targeting cancer stem cells via inhibiting ABCG2 protein and cancer stem cells niche via inhibing cancer angiogenesis, we recently established an effective way to treat chemoresistant lung cancer. Preliminary clinical results are quite encouraging especially on malignant pleural effusion. Currently, I am investigating efficiency and safety of the method in treating both chemo-resistant and non-chemo-resistant lung cancer.
Dr. Hemant Agarwal is a pediatrician in Albuquerque, New Mexico and is affiliated with multiple hospitals in the area, including Jackson-Madison County General Hospital and Vanderbilt Hospital and Clinics. He received his medical degree from Seth G.S. Medical College and has been in practice for 25 years. He is one of 20 doctors at Jackson-Madison County General Hospital and one of 175 at Vanderbilt Hospital and Clinics who specialize in Pediatrics.
Dr. Hemant Agarwal is a pediatrician in Albuquerque, New Mexico and is affiliated with multiple hospitals in the area, including Jackson-Madison County General Hospital and Vanderbilt Hospital and Clinics. He received his medical degree from Seth G.S. Medical College and has been in practice for 25 years. He is one of 20 doctors at Jackson-Madison County General Hospital and one of 175 at Vanderbilt Hospital and Clinics who specialize in Pediatrics.
Dr. Jian Fu is an associate professor at Department of Toxicology and Cancer biology, College of Medicine, University of Kentucky. Dr. Fu received his Ph.D. degree from university of Alabama at Birmingham. Dr. Fus research focuses on lung inflammation, injury and repair, and epigenetic regulation of lung inflammation and carcinogenesis by environmental toxicants. Dr. Fu served on grant review panels for NIH on LCMI (Lung Cellular, Molecular, And Immunobiology), III (Innate Immunity And Inflammation), and RIBT (Respiratory Integrative Biology and Translational Research) Study Sections. Dr. Fu is a member of the Grant Review Panel for American Heart Association on Lung
Dr. Jian Fu is an associate professor at Department of Toxicology and Cancer biology, College of Medicine, University of Kentucky. Dr. Fu received his Ph.D. degree from university of Alabama at Birmingham. Dr. Fus research focuses on lung inflammation, injury and repair, and epigenetic regulation of lung inflammation and carcinogenesis by environmental toxicants. Dr. Fu served on grant review panels for NIH on LCMI (Lung Cellular, Molecular, And Immunobiology), III (Innate Immunity And Inflammation), and RIBT (Respiratory Integrative Biology and Translational Research) Study Sections. Dr. Fu is a member of the Grant Review Panel for American Heart Association on Lung study section. Dr. Fu also serve as Academic Editor for PLOS ONE on pulmonary research and critical care medicine.
Dr. Li is an internationally recognized expert in the field of surgical pathology and cytopathology, and faculty of the Johns Hopkins Biomarker Discovery Center. She provides diagnostic surgical pathology and cytopathology service at Johns Hopkins Medical Centers, and conducts research in the field of novel biomarkers in lung cancer and diseases. Her work has been presented at numerous national/international meetings. She also conducts CME courses and workshops, serves as keynote speaker and organizer for international conferences, editorial board member for several journals, committee member of the American Society of Cytopathology and the Papanicolaou Society of Cytopathology, and study section of
Dr. Li is an internationally recognized expert in the field of surgical pathology and cytopathology, and faculty of the Johns Hopkins Biomarker Discovery Center. She provides diagnostic surgical pathology and cytopathology service at Johns Hopkins Medical Centers, and conducts research in the field of novel biomarkers in lung cancer and diseases. Her work has been presented at numerous national/international meetings. She also conducts CME courses and workshops, serves as keynote speaker and organizer for international conferences, editorial board member for several journals, committee member of the American Society of Cytopathology and the Papanicolaou Society of Cytopathology, and study section of government agents and private organizations. She has more than 100 publications, including book and book chapters. She is also the co-editor of "Diagnostic Cytopathology Board Review and Self-Assessment".
Dr. Karnatovskaia received BA in psychology from Florida International University and then MS in psychology from the University of Miami. She then received MD from the University of Florida in Gainesville, FL. She completed residency in internal medicine at the University of Florida and pulmonary/critical care fellowship at the Mayo Clinic in Jacksonville, FL. Dr. Karnatovskaia is currently an assistant professor in the division of pulmonary and critical care medicine at the Mayo Clinic, Rochester. Her research interests include aspects of critical care including targeted temperature management and investigation of psychocognitive sequelae of the ICU stay and their prevention.
Dr. Karnatovskaia received BA in psychology from Florida International University and then MS in psychology from the University of Miami. She then received MD from the University of Florida in Gainesville, FL. She completed residency in internal medicine at the University of Florida and pulmonary/critical care fellowship at the Mayo Clinic in Jacksonville, FL. Dr. Karnatovskaia is currently an assistant professor in the division of pulmonary and critical care medicine at the Mayo Clinic, Rochester. Her research interests include aspects of critical care including targeted temperature management and investigation of psychocognitive sequelae of the ICU stay and their prevention.
Dr. Roy Raad is a radiologist in New York, USA. He received his medical degree from University of Balamand Faculty of Medicine. He is research fellow for PET-CT imaging fellow in New York University Hositals center. He received Award and Honor from Balamand University. He is Member for Radiological Society of North America in 2008. In 2013 to Present he is an active member for Society of Nuclear Medicine and Molecular Imaging.
Dr. Roy Raad is a radiologist in New York, USA. He received his medical degree from University of Balamand Faculty of Medicine. He is research fellow for PET-CT imaging fellow in New York University Hositals center. He received Award and Honor from Balamand University. He is Member for Radiological Society of North America in 2008. In 2013 to Present he is an active member for Society of Nuclear Medicine and Molecular Imaging.
I believe to understand where and how our patients live, get sick and heal is an important part of medicine. And art illuminates science and medicine. I live in Lower East Side Manhattan. This is a frosty city within a city especially beautiful in snow, but it could also be beautiful in rain, and in sunshine when it must. This is a city never asks poor new immigrants like my parents not to come. This is used to be Dicken's underbelly and Steinback's East of Eden. It was called 5-points in the time of President Lincoln when war broken over
I believe to understand where and how our patients live, get sick and heal is an important part of medicine. And art illuminates science and medicine. I live in Lower East Side Manhattan. This is a frosty city within a city especially beautiful in snow, but it could also be beautiful in rain, and in sunshine when it must. This is a city never asks poor new immigrants like my parents not to come. This is used to be Dicken's underbelly and Steinback's East of Eden. It was called 5-points in the time of President Lincoln when war broken over a pair of shoes. There are narrow streets on Mulberry with arts shops make one's head spin like the spiral shell of a snail, like the spinning bicycle wheels on spikes. Along the Orchard where in flower shops rosemary is dropping a hint of petals moved by the wind (Nauticaa, Robert Frost). Kindness hunts for self-seekers here in 5 points. I have published a number of books and papers related to oncology, radiation oncology in particular, global epidemiology and public health of oncology of oncology and pollution. There will be a major challenge of cancer epidemic in the world related to environment and life style. Try to understand various challenges facing patients, cancer patients in particular, is the focus of my work. Think knowledge and kindness, the world will be a better place.
Dr. Szczesny received BA, MS and PhD from the University of Wroclaw, Poland. He completed his post-doctoral training at the University of Texas Medical Branch in Galveston, USA. His research training includes Strathclyde University Glasgow, Scotland; Lund University, Sweden; and University in Louvain la Neuve, Belgium. He is currently Assistant Professor in the Department of Anesthesiology at the University of Texas Medical Branch and Staff Scientists at the Shriners Hospital for Children in Galveston. Dr. Szczesny is an expert in mitochondrial DNA damage and repair and signaling of mitochondrial dysfunction in various pathological conditions. His major research interests are mitochondrial
Dr. Szczesny received BA, MS and PhD from the University of Wroclaw, Poland. He completed his post-doctoral training at the University of Texas Medical Branch in Galveston, USA. His research training includes Strathclyde University Glasgow, Scotland; Lund University, Sweden; and University in Louvain la Neuve, Belgium. He is currently Assistant Professor in the Department of Anesthesiology at the University of Texas Medical Branch and Staff Scientists at the Shriners Hospital for Children in Galveston. Dr. Szczesny is an expert in mitochondrial DNA damage and repair and signaling of mitochondrial dysfunction in various pathological conditions. His major research interests are mitochondrial dysfunction in acute lung injury, pathophysiological role of mitochondrial DNA damage in burn injury and targeting mitochondria in lung cancer.
Dr. Igor Koturbash is an Assistant Professor at the Department of Environmental and Occupational Health, University Arkansas for Medical Sciences (Little Rock, AR). He received his M.D. from the State Medical University in Ivano-Frankivsk, Ukraine (2001), and his Ph.D. in Molecular Biology from the University of Lethbridge, Canada (2008). Dr. Koturbash completed his training as an Oak Ridge Institute for Science and Education Research (ORISE) Fellow at the National Center for Toxicological Research, US Food and Drug Administration in Jefferson, AR. Igors primary research interests are devoted to epigenetic mechanisms of response to environmental stressors, with particular emphasis on repetitive
Dr. Igor Koturbash is an Assistant Professor at the Department of Environmental and Occupational Health, University Arkansas for Medical Sciences (Little Rock, AR). He received his M.D. from the State Medical University in Ivano-Frankivsk, Ukraine (2001), and his Ph.D. in Molecular Biology from the University of Lethbridge, Canada (2008). Dr. Koturbash completed his training as an Oak Ridge Institute for Science and Education Research (ORISE) Fellow at the National Center for Toxicological Research, US Food and Drug Administration in Jefferson, AR. Igors primary research interests are devoted to epigenetic mechanisms of response to environmental stressors, with particular emphasis on repetitive elements and DNA methylation.
Dr. Luo is an assistant professor in the Department of Biomedical Informatics at University of Utah. He received his Bachelors degree in Computer Science from Shanghai Jiaotong University, P.R. China, in June 1998. He obtained his Ph.D. degree in Computer Science minor in Mathematics at the University of Wisconsin-Madison in June 2004. He was a Research Staff Member at IBM T.J. Watson research center between July 2004 and August 2012. In collaboration with many researchers worldwide, he founded the International Health Informatics Symposium (IHI) in 2010. He has authored 50+ papers and holds 20+ patents. His research interests include health
Dr. Luo is an assistant professor in the Department of Biomedical Informatics at University of Utah. He received his Bachelors degree in Computer Science from Shanghai Jiaotong University, P.R. China, in June 1998. He obtained his Ph.D. degree in Computer Science minor in Mathematics at the University of Wisconsin-Madison in June 2004. He was a Research Staff Member at IBM T.J. Watson research center between July 2004 and August 2012. In collaboration with many researchers worldwide, he founded the International Health Informatics Symposium (IHI) in 2010. He has authored 50+ papers and holds 20+ patents. His research interests include health informatics (system building and data analysis), information retrieval, database, natural language processing, machine learning, and data mining.
Originally from Mashad, Khorasan, Iran, I have received my Bachelor of Chemistry degree from Shiraz University, Iran in 1989. I then completed my Master of Science and PhD degree in the Department of Clinical Biochemistry at Tarbiat Modarres University, Iran in 1996 and 2004 under the supervisions of Dr. Lotfi and Karami Tehrani respectively. Prior to joining to the Department of Human Anatomy and Cell Science University of Manitoba in October 2013 as an Assistant Professor/Principal Investigator, I worked as a postdoctoral fellow in the laboratory of Dr. Marek Los (CancerCare Manitoba), Dr. Andrew J. Halayko (Department of Physiology) and
Originally from Mashad, Khorasan, Iran, I have received my Bachelor of Chemistry degree from Shiraz University, Iran in 1989. I then completed my Master of Science and PhD degree in the Department of Clinical Biochemistry at Tarbiat Modarres University, Iran in 1996 and 2004 under the supervisions of Dr. Lotfi and Karami Tehrani respectively. Prior to joining to the Department of Human Anatomy and Cell Science University of Manitoba in October 2013 as an Assistant Professor/Principal Investigator, I worked as a postdoctoral fellow in the laboratory of Dr. Marek Los (CancerCare Manitoba), Dr. Andrew J. Halayko (Department of Physiology) and Dr. Ian MC Dixon (Department of Physiology) at University of Manitoba. His research interests are Role of Autophagy and UPR in Regulation of Transforming Growth Factor beta 1 (TGF-1)-induced Epithelial Mesenchymal Transition (EMT) in Lung Cancer Model, Targeting Mevalonate Cascade as New Approach for Breast Cancer Therapeutic Strategies, Modulation of Influenza Virus Replication by Targeting Apoptosis.
I am currently assistant professor of thoracic oncology at University Hospitals, Case Western Reserve University, Cleveland, Ohio. I have also held faculty position at Roswell Park Cancer Institute, Buffalo, NY, where I completed medical oncology fellowship in 2010. I completed residency in internal medicine from John H Stroger Hospital, Rush University, Chicago, in 2008. Before joining the residency I completed PhD in Pharmacology at University of Georgia in 2005. I attended G.S.V.M. Medical College in India from 1996 to 2001. Research Interest are I am a medical oncologist with interest in translating bench side research to early phase clinical trials.
I am currently assistant professor of thoracic oncology at University Hospitals, Case Western Reserve University, Cleveland, Ohio. I have also held faculty position at Roswell Park Cancer Institute, Buffalo, NY, where I completed medical oncology fellowship in 2010. I completed residency in internal medicine from John H Stroger Hospital, Rush University, Chicago, in 2008. Before joining the residency I completed PhD in Pharmacology at University of Georgia in 2005. I attended G.S.V.M. Medical College in India from 1996 to 2001. Research Interest are I am a medical oncologist with interest in translating bench side research to early phase clinical trials. My research focus is to find novel treatment options for EGFR TKI resistant non small cell lung cancer and treatment of KRAS mutant lung cancer. We have shown that combination of EGFR inhibitors with a new class of drugs (curaxins) can increase the efficacy of EGFR TKI in otherwise resistant non small cell lung cancer cell lines. Curaxins can simultaneously suppress NF-kappaB and activate p53 by targeting FACT. Based on this work I am conducting a Phase I clinical trial of erlotinib and quinacrine in advanced lung cancer patients. Together with Dr. Goutham Narla at Case Western Reserve University, I am investigating a novel class of drugs that activate serine/threonine phosphatase PP2A and simultaneously inhibit the MEK and AKT pathway. We have shown robust pre-clinical activity of this compound in various models of KRAS mutant lung cancer and are in process of initiating early phase clinical trials in solid tumors.
Ting Wang is an Assistant Professor in the Division of Pulmonary, Allergy, Critical Care, & Sleep Medicine, Department of Medicine, the University of Arizona (UA). He is also a member of Southwest Environmental Health Sciences Center and a faculty member of the Physiological Science Graduate Interdisciplinary Program at UA. He received postdoctoral fellowship training at the University of Chicago and his Ph.D. degree in Pharmaceutical Sciences from University of South Carolina in 2005. Dr. Wangs research interests lie in three areas, including cardiopulmonary toxicity of particulate matter (PM) air pollution; lung biology of acute lung injury and asthma mediated by
Ting Wang is an Assistant Professor in the Division of Pulmonary, Allergy, Critical Care, & Sleep Medicine, Department of Medicine, the University of Arizona (UA). He is also a member of Southwest Environmental Health Sciences Center and a faculty member of the Physiological Science Graduate Interdisciplinary Program at UA. He received postdoctoral fellowship training at the University of Chicago and his Ph.D. degree in Pharmaceutical Sciences from University of South Carolina in 2005. Dr. Wangs research interests lie in three areas, including cardiopulmonary toxicity of particulate matter (PM) air pollution; lung biology of acute lung injury and asthma mediated by key genes such as MYLK; Lung genomics and genetics such as mRNA structural sensitive single-nucleotide polymorphisms (SNPs) manipulated gene expression regulation. He is the author of over thirty peer-reviewed research articles. In 2012, he was awarded a Parker B. Francis Fellowship in Pulmonary Biology and Respiratory Disease. Research Interest includes, Cardiopulmonary toxicity of particulate matter air pollution, Lung biology of acute lung injury and asthma, Lung genomics and genetics.
Stefano Mazzoleni received Dr. Eng. Degree in Computer Engineering from the University of Pisa (Italy) in 2002 and the Ph.D . in Biomedical Engineering from the University of Genoa (Italy) in 2007. In 2005 he received the 'Student Travel Award' during the IEEE 9th International Conference on Rehabilitation Robotics in Chicago (USA) and he was Visiting Researcher at the Department of Neurophysiology, Katholieke Universiteit Leuven, Belgium. Since 2011 he is coordinator and member of the Scientific Committee of the 'Rehabilitation Bioengineering Laboratory' in Volterra (Italy), joint research laboratory between Scuola Superiore Sant'Anna and'Auxilium Vitae' Rehabilitation Centre. He is member of the
Stefano Mazzoleni received Dr. Eng. Degree in Computer Engineering from the University of Pisa (Italy) in 2002 and the Ph.D . in Biomedical Engineering from the University of Genoa (Italy) in 2007. In 2005 he received the 'Student Travel Award' during the IEEE 9th International Conference on Rehabilitation Robotics in Chicago (USA) and he was Visiting Researcher at the Department of Neurophysiology, Katholieke Universiteit Leuven, Belgium. Since 2011 he is coordinator and member of the Scientific Committee of the 'Rehabilitation Bioengineering Laboratory' in Volterra (Italy), joint research laboratory between Scuola Superiore Sant'Anna and'Auxilium Vitae' Rehabilitation Centre. He is member of the Scientific and Technical Committee of 'Auxilium Vitae' Rehabilitation Centre. Since 2003 he is Assistant Professor at the University of Pisa at School of Engineering and since 2009 he is Lecturer at the Specialization School in Physical Medicine and Rehabilitation, Faculty of Medicine and Surgery. Since 2012 he is serving as co-chair in the IEEE/RAS Technical Committee on 'Rehabilitation and Assistive Robotics'. He has authored/co-authored about 60 peer-reviewed publications in international journals, books and conference proceedings.
Dr. Ryland P. Byrd, Jr. is a board certified pulmonary physician. He received his internal medicine and pulmonary training at the University of Louisville. He remained on the faculty of the Division of Respiratory and Occupational Medicineat the University of Louisville for two years. He subsequently joined the faculty of the Division of Pulmonary Diseases and Critical Care Medicine at Quillen College of Medicine in Johnson City, TN. He is currently a practicing pulmonary and critical care physician and full professor at East Tennessee State University in Johnson City, Tennessee. Research interests include, Pleural effusions, pneumothorax, tuberculosis, fungal infection of
Dr. Ryland P. Byrd, Jr. is a board certified pulmonary physician. He received his internal medicine and pulmonary training at the University of Louisville. He remained on the faculty of the Division of Respiratory and Occupational Medicineat the University of Louisville for two years. He subsequently joined the faculty of the Division of Pulmonary Diseases and Critical Care Medicine at Quillen College of Medicine in Johnson City, TN. He is currently a practicing pulmonary and critical care physician and full professor at East Tennessee State University in Johnson City, Tennessee. Research interests include, Pleural effusions, pneumothorax, tuberculosis, fungal infection of the lower respiratory tract.
Dr. Sheyin received his medical degree from the University of Ibadan, Nigeria. Thereafter he underwent residency training in internal medicine at the Lagos University Teaching Hospital Nigeria, and at the Columbia University Medical Center, Harlem Hospital New York. He will be completing his residency training in June 2015 and he has been appointed Chief Resident, Department of Medicine at Columbia University Medical Center, Harlem Hospital New York. His research interest is in biomarkers in cardiovascular and critical care medicine.
Dr. Sheyin received his medical degree from the University of Ibadan, Nigeria. Thereafter he underwent residency training in internal medicine at the Lagos University Teaching Hospital Nigeria, and at the Columbia University Medical Center, Harlem Hospital New York. He will be completing his residency training in June 2015 and he has been appointed Chief Resident, Department of Medicine at Columbia University Medical Center, Harlem Hospital New York. His research interest is in biomarkers in cardiovascular and critical care medicine.
Dr. Ogunbileje has a master degree in clinical chemistry from the premier university in Nigeria, University of Ibadan. His PhD research was focused on the roles of particulate matters and its contents in the induction of lung injury and fibrosis. He demonstrated that cement dust particle which is known as the most occupational dust particles exposed to by workers contains carcinogenic metals and other metals that can contribute/induce other debilitating health conditions. For the first time, his work clarified the discrepancies in epidemiological data available on cement dust factory workers in relationship with the prevalence of cancer. He was able
Dr. Ogunbileje has a master degree in clinical chemistry from the premier university in Nigeria, University of Ibadan. His PhD research was focused on the roles of particulate matters and its contents in the induction of lung injury and fibrosis. He demonstrated that cement dust particle which is known as the most occupational dust particles exposed to by workers contains carcinogenic metals and other metals that can contribute/induce other debilitating health conditions. For the first time, his work clarified the discrepancies in epidemiological data available on cement dust factory workers in relationship with the prevalence of cancer. He was able to show that cement dust metal contents is factory dependent. Dr. Ogunbileje further demonstrated the interactions of cement dust particles with lung cells and contributed significantly to the understanding of the mechanism of cement dust particles-induced lung injury. Besides the interaction of cement dust particles with the lung cells, he has also shown the systemic effects of cement dust particles especially with the antibody-mediated immune response (Humoral) and renal pathology. Recently, Dr. Ogunbileje and his team at the University of Texas Medical Branch are looking into the effect of cocaine and cocaethyelene on lung alveolar linin.
Dr Ranjan Pathak is resident physician at the Reading Health System, Pennsylvania, United States. He did his undergraduate training from the prestigious Nepal Medical College, in Kathmandu, Nepal. He has wide ranging research interests with systematic reviews and meta-analyses to Big Data research. Dr Pathaks research areas in pulmonary medicine include use of newer anticoagulants for deep vein thrombosis/pulmonary embolism, health outcomes research on PE and its complications. Results of his studies have been published in more than 35 peer review articles.
Dr Ranjan Pathak is resident physician at the Reading Health System, Pennsylvania, United States. He did his undergraduate training from the prestigious Nepal Medical College, in Kathmandu, Nepal. He has wide ranging research interests with systematic reviews and meta-analyses to Big Data research. Dr Pathaks research areas in pulmonary medicine include use of newer anticoagulants for deep vein thrombosis/pulmonary embolism, health outcomes research on PE and its complications. Results of his studies have been published in more than 35 peer review articles.
Alireza Haghighi, MD, DPhil is a clinician scientist. He graduated from University of Oxford and is currently based at the Department of Genetics of Harvard Medical School and Brigham and Womens Hospital. His research focuses on clinical and genetic investigation of inherited diseases, using state of the art technologies such as high throughput genotyping and next generation sequencing. He is also working on translating basic research discoveries into better diagnostics and improved management strategies, and opportunities for developing novel therapeutics to treat disease.
Alireza Haghighi, MD, DPhil is a clinician scientist. He graduated from University of Oxford and is currently based at the Department of Genetics of Harvard Medical School and Brigham and Womens Hospital. His research focuses on clinical and genetic investigation of inherited diseases, using state of the art technologies such as high throughput genotyping and next generation sequencing. He is also working on translating basic research discoveries into better diagnostics and improved management strategies, and opportunities for developing novel therapeutics to treat disease.
I am a graduate of B. J. Medical College, one of the top ten medical schools in India. I did my internship at Ahmedabad Civil Hospital. After those rotations, I spent a year in learning epidemiology and research statistics at Brown University, Rhode Island, USA. I also volunteered as a Research Assistant at Brown University for one year and at University of Miami Miller School of Medicine for six months in Department of Cardiology. Currently, I am a 3rd year Internal Medicine resident at Staten Island University Hospital. My interest in the field of clinical research lies in Quality
I am a graduate of B. J. Medical College, one of the top ten medical schools in India. I did my internship at Ahmedabad Civil Hospital. After those rotations, I spent a year in learning epidemiology and research statistics at Brown University, Rhode Island, USA. I also volunteered as a Research Assistant at Brown University for one year and at University of Miami Miller School of Medicine for six months in Department of Cardiology. Currently, I am a 3rd year Internal Medicine resident at Staten Island University Hospital. My interest in the field of clinical research lies in Quality Improvement projects. My research is focused on determining optimal clinical strategies and identifying opportunities to advance the quality of health care in a cost-effective way. I am also interested in epidemiology research with an intention to improve our knowledge of various cardiovascular and non-cardiovascular diseases. Using the national administrative database, I have also sought to identify various hospital characteristics to improve cost-effectiveness and outcomes of specific clinical approaches and procedures.
Steve Pappas earned his B.S. in Chemistry at Middle Tennessee State University. He completed his graduate training in Biochemistry at Vanderbilt University. After faculty positions at Middle Tennessee State University and Georgia State University, he was employed at the Centers for Disease Control and Prevention (CDC) to develop methods for analysis of toxic metals in urine and blood for emergency response state health department laboratory training. In the second phase of his work at CDC, he became responsible for development of methods for analysis of tobacco and smoke for toxic metals. He became the Tobacco Inorganics Group Team Lead.
Steve Pappas earned his B.S. in Chemistry at Middle Tennessee State University. He completed his graduate training in Biochemistry at Vanderbilt University. After faculty positions at Middle Tennessee State University and Georgia State University, he was employed at the Centers for Disease Control and Prevention (CDC) to develop methods for analysis of toxic metals in urine and blood for emergency response state health department laboratory training. In the second phase of his work at CDC, he became responsible for development of methods for analysis of tobacco and smoke for toxic metals. He became the Tobacco Inorganics Group Team Lead. He oversees method development, ISO 17025 accreditation, and analyses for toxic metals in tobacco and smoke. He is responsible for publishing and interpreting data in terms of public health risks. In addition to application manuscripts, he has written the Annex behind World Health Organization Technical Report Series 967 on toxic metals in tobacco and smoke with emphasis on inflammation and sensitization responses in animal and human studies, and a Metallomics review on the same topic.
Dr. Sachin Atre currently serves as a technical Consultant on an assignment for the World Health Organization, Geneva. Before that he was a Fulbright-Nehru Post doc fellow at the Department of Global Health and Social Medicine at Harvard Medical School, USA during Sept.2013- Sept.2014. Dr. Atre has received Masters degree and Ph.D. in Medical Anthropology from the University Of Pune in 2008. He has spent nearly 14 years in public health research. His work is mainly focused on biosocial aspects of tuberculosis and multidrug-resistant tuberculosis (MDR-TB). His other areas of research include ageing, nutrition, leprosy, diabetes and access to medicines.
Dr. Sachin Atre currently serves as a technical Consultant on an assignment for the World Health Organization, Geneva. Before that he was a Fulbright-Nehru Post doc fellow at the Department of Global Health and Social Medicine at Harvard Medical School, USA during Sept.2013- Sept.2014. Dr. Atre has received Masters degree and Ph.D. in Medical Anthropology from the University Of Pune in 2008. He has spent nearly 14 years in public health research. His work is mainly focused on biosocial aspects of tuberculosis and multidrug-resistant tuberculosis (MDR-TB). His other areas of research include ageing, nutrition, leprosy, diabetes and access to medicines. He has been trained in mixed (qualitative and quantitative) research methods applied for community-based studies. He has worked in international collaborations with European and African partners and also contributed as a lead author in several international peer-reviewed publications. Currently he is a member of International Consortium for Research and Action against Health-related stigma (ICRAAS), Amsterdam, Netherlands. He served as an invited reviewer for some international journals like WHO Bulletin, Infant, Child, & Adolescent Nutrition (ICAN) in San Francisco, USA and Indian Journal of Public Health.
Dr. Kheir received his medical degree from University of Balamand, Lebanon. He completed his fellowship training at Tulane in Pulmonary and Critical Care Medicine in 2013, subsequently joining the Tulane faculty as an Assistant Professor of Clinical Medicine. Recently, he completed Masters of Science in Clinical Research. Dr. Kheir is board certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine. He is a member of the American College of Chest Physicians and the American Thoracic Society. His clinical and research interests includes are thoracic and critical care ultrasound use, medical education, pleural diseases and mechanical ventilation. His main focus
Dr. Kheir received his medical degree from University of Balamand, Lebanon. He completed his fellowship training at Tulane in Pulmonary and Critical Care Medicine in 2013, subsequently joining the Tulane faculty as an Assistant Professor of Clinical Medicine. Recently, he completed Masters of Science in Clinical Research. Dr. Kheir is board certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine. He is a member of the American College of Chest Physicians and the American Thoracic Society. His clinical and research interests includes are thoracic and critical care ultrasound use, medical education, pleural diseases and mechanical ventilation. His main focus of interest is on Lung ultrasound, Lung cancer, Endobronchial ultrasound, Respiratory Tract Infection, Pleural diseases.
During both my training and work as a staff physician in the department of Pulmonary, critical care and sleep medicine. I have been interested in pulmonary vascular disease including pulmonary hypertension. I also find it fascinating how sleep disorders affect various pulmonary diseases and have strived to research this link between the two diseases. As a teacher to residents and nurses, i have been imparted education on bronchoscopy, ventilatory management of pulmonary diseases.
During both my training and work as a staff physician in the department of Pulmonary, critical care and sleep medicine. I have been interested in pulmonary vascular disease including pulmonary hypertension. I also find it fascinating how sleep disorders affect various pulmonary diseases and have strived to research this link between the two diseases. As a teacher to residents and nurses, i have been imparted education on bronchoscopy, ventilatory management of pulmonary diseases.
All articles are fully peer reviewed, free to access and can be downloaded from our ClinMed archive.
Clinical Medical Image Library: 93.51
International Journal of Critical Care and Emergency Medicine: 92.83
International Journal of Sports and Exercise Medicine: 91.84
International Journal of Womens Health and Wellness: 91.79
Journal of Musculoskeletal Disorders and Treatment: 91.73
Journal of Geriatric Medicine and Gerontology: 91.55
Journal of Infectious Diseases and Epidemiology: 91.55
Clinical Medical Reviews and Case Reports: 91.40
International Archives of Nursing and Health Care: 90.87
International Journal of Ophthalmology and Clinical Research: 90.80
International Archives of Urology and Complications: 90.73
Journal of Clinical Nephrology and Renal Care: 90.33
Journal of Family Medicine and Disease Prevention: 89.99
Journal of Clinical Gastroenterology and Treatment: 89.54
Journal of Dermatology Research and Therapy: 89.34
International Journal of Clinical Cardiology: 89.24
International Journal of Radiology and Imaging Technology: 88.88
Obstetrics and Gynaecology Cases - Reviews: 88.42
International Journal of Blood Research and Disorders: 88.22
International Journal of Diabetes and Clinical Research: 87.97